Reactive astrogliosis, routinely observed immunohistochemically as an increase in GFAP signal, is one of the central features of prion and other neurodegenerative diseases (Kovacs et al., 2013; Jeffrey et al., 2014; Katorcha et al., 2018). Here, GFAP is linked to neurodegenerative disease.